Elucidating cardiovascular phenotaypes employing genome editing of iPS cells
利用 iPS 细胞基因组编辑阐明心血管表型
基本信息
- 批准号:8094604
- 负责人:
- 金额:$ 61.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-05 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:9p21Abdominal Aortic AneurysmAffectArchitectureBlood VesselsCardiovascular systemCellsChromatinCollectionComplexCoronary ArteriosclerosisDNADataDiseaseElderlyEndotheliumGenerationsGenesGeneticGenetic TranscriptionGenetic VariationGenomeGenomicsGenotypeHaplotypesHuman GeneticsIndividualIntracranial AneurysmMeasuresModelingMolecularMyocardial InfarctionOpen Reading FramesPatientsPhasePhenotypePrincipal InvestigatorRiskSmooth MuscleSmooth Muscle MyocytesStretchingTechnologyVariantcohortevidence basegenome wide association studyinduced pluripotent stem cellinnovationprotective effectsmall moleculetool
项目摘要
DESCRIPTION (provided by applicant):
We aim to develop an innovative approach to generate, at high-throughput, isogenic induced pluripotent stem cells (iPSCs), and use their differentiated progeny to understand the impact of human genetic variation on the risk of developing coronary artery disease (CAD). A genomic variant associated with CAD, myocardial infarction (Ml), abdominal aortic aneurysm, and intracranial aneurysm is found in a stretch of chr9p21 devoid of known genes. We will use this locus as a model for our study; while focusing on 9p21, our overall approach will be broadly applicable to the study of HLBS diseases of complex genetic architecture.
描述(由申请人提供):
我们的目标是开发一种创新方法,以高通量生成同基因诱导多能干细胞 (iPSC),并利用其分化后代来了解人类遗传变异对患冠状动脉疾病 (CAD) 风险的影响。在缺乏已知基因的 chr9p21 片段中发现了与 CAD、心肌梗塞 (MI)、腹主动脉瘤和颅内动脉瘤相关的基因组变异。我们将使用这个基因座作为我们研究的模型;在关注 9p21 的同时,我们的整体方法将广泛适用于复杂遗传结构的 HLBS 疾病的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samuel Levy其他文献
Samuel Levy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samuel Levy', 18)}}的其他基金
NHLBI DNA RE-SEQUENCING AND GENOTYPING PROGRAM LABORATORY CENTER
NHLBI DNA 重测序和基因分型计划实验室中心
- 批准号:
7542645 - 财政年份:2004
- 资助金额:
$ 61.69万 - 项目类别:
相似海外基金
Establishment of human abdominal aortic aneurysm wall strength prediction model using Ex Vivo Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging
利用Ex Vivo超顺磁性氧化铁建立人体腹主动脉瘤壁强度预测模型
- 批准号:
23K08226 - 财政年份:2023
- 资助金额:
$ 61.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
- 批准号:
10733477 - 财政年份:2023
- 资助金额:
$ 61.69万 - 项目类别:
Extracellular Vesicle Delivery System for Treatment of Abdominal Aortic Aneurysm
细胞外囊泡递送系统治疗腹主动脉瘤
- 批准号:
10751123 - 财政年份:2023
- 资助金额:
$ 61.69万 - 项目类别:
I-Corps: A Clinical Decision Support Tool to Manage Abdominal Aortic Aneurysm Patients
I-Corps:管理腹主动脉瘤患者的临床决策支持工具
- 批准号:
2318665 - 财政年份:2023
- 资助金额:
$ 61.69万 - 项目类别:
Standard Grant
Atherosclerosis drives arterial damage and abdominal aortic aneurysm formation and rupture
动脉粥样硬化导致动脉损伤和腹主动脉瘤形成和破裂
- 批准号:
483212 - 财政年份:2023
- 资助金额:
$ 61.69万 - 项目类别:
Operating Grants
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm
开发基于磷脂的纳米疗法治疗腹主动脉瘤
- 批准号:
10749980 - 财政年份:2023
- 资助金额:
$ 61.69万 - 项目类别:
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growth
PCSK9 抑制对腹主动脉瘤病理学和生长的影响
- 批准号:
10566800 - 财政年份:2023
- 资助金额:
$ 61.69万 - 项目类别:
The Role of Amino Acid Starvation Response Kinase GCN2 in Abdominal Aortic Aneurysm
氨基酸饥饿反应激酶 GCN2 在腹主动脉瘤中的作用
- 批准号:
10584543 - 财政年份:2022
- 资助金额:
$ 61.69万 - 项目类别:
Atherosclerotic process drives arterial damage, abdominal aortic aneurysm formation, and rupture
动脉粥样硬化过程导致动脉损伤、腹主动脉瘤形成和破裂
- 批准号:
477264 - 财政年份:2022
- 资助金额:
$ 61.69万 - 项目类别:
Operating Grants
Endovascular Orifice Detection (EOrD) Device for in situ Fenestration of Abdominal Aortic Aneurysm
用于腹主动脉瘤原位开窗的血管内孔口检测 (EOrD) 装置
- 批准号:
10453104 - 财政年份:2022
- 资助金额:
$ 61.69万 - 项目类别: